[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT1218420B - Agenti terapeutici comprendenti 3-1 (immidazolilalchil) indoli (e loro sali di addizione) - Google Patents

Agenti terapeutici comprendenti 3-1 (immidazolilalchil) indoli (e loro sali di addizione)

Info

Publication number
IT1218420B
IT1218420B IT20399/80A IT2039980A IT1218420B IT 1218420 B IT1218420 B IT 1218420B IT 20399/80 A IT20399/80 A IT 20399/80A IT 2039980 A IT2039980 A IT 2039980A IT 1218420 B IT1218420 B IT 1218420B
Authority
IT
Italy
Prior art keywords
immidazolylalkyl
indoles
therapeutic agents
addition salts
agents including
Prior art date
Application number
IT20399/80A
Other languages
English (en)
Other versions
IT8020399A0 (it
Inventor
Peter Edward Cross
Roger Peter Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IT8020399A0 publication Critical patent/IT8020399A0/it
Application granted granted Critical
Publication of IT1218420B publication Critical patent/IT1218420B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT20399/80A 1979-03-07 1980-03-06 Agenti terapeutici comprendenti 3-1 (immidazolilalchil) indoli (e loro sali di addizione) IT1218420B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7908123 1979-03-07

Publications (2)

Publication Number Publication Date
IT8020399A0 IT8020399A0 (it) 1980-03-06
IT1218420B true IT1218420B (it) 1990-04-19

Family

ID=10503707

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20399/80A IT1218420B (it) 1979-03-07 1980-03-06 Agenti terapeutici comprendenti 3-1 (immidazolilalchil) indoli (e loro sali di addizione)

Country Status (36)

Country Link
US (1) US4273782A (it)
JP (1) JPS55133380A (it)
KR (1) KR850000760B1 (it)
AR (1) AR227015A1 (it)
AT (1) AT375366B (it)
AU (1) AU516957B2 (it)
BE (1) BE882113A (it)
CA (1) CA1120479A (it)
CH (1) CH649546A5 (it)
CS (1) CS253702B2 (it)
DD (1) DD149525A5 (it)
DE (1) DE3008632A1 (it)
DK (1) DK151884C (it)
ES (2) ES8104278A1 (it)
FI (1) FI66860C (it)
FR (1) FR2450832A1 (it)
GR (1) GR67237B (it)
HK (1) HK89884A (it)
HU (1) HU184727B (it)
IE (1) IE49542B1 (it)
IL (1) IL59524A (it)
IT (1) IT1218420B (it)
KE (1) KE3467A (it)
LU (1) LU82224A1 (it)
MY (1) MY8500285A (it)
NL (1) NL182959C (it)
NO (1) NO152217C (it)
NZ (1) NZ193052A (it)
PH (1) PH15198A (it)
PL (1) PL128296B1 (it)
PT (1) PT70914A (it)
SE (1) SE440778B (it)
SG (1) SG67284G (it)
SU (1) SU1277894A3 (it)
YU (1) YU41911B (it)
ZA (1) ZA801328B (it)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414159A (en) * 1980-09-26 1983-11-08 E. I. Du Pont De Nemours & Co. Vinyl ether monomers and polymers therefrom
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
KR840000529A (ko) * 1981-07-07 1984-02-25 콘스탄틴 루이스 클레멘트 인돌 유도체의 제조방법
ZA825413B (en) * 1981-08-26 1983-06-29 Pfizer Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4539410A (en) * 1982-09-30 1985-09-03 Ciba-Geigy Corporation N-Substituted-2-(1-imidazolyl)indoles
US4436746A (en) 1982-09-30 1984-03-13 Ciba-Geigy Corporation Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
AT376436B (de) * 1982-11-05 1984-11-26 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
EP0239306B1 (en) 1986-03-27 1993-06-02 Merck Frosst Canada Inc. Tetrahydrocarbazole esters
JPH0832679B2 (ja) * 1986-09-05 1996-03-29 理化学研究所 Ｎ―フタルイシド誘導体及びその製造法
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
CA2030557A1 (en) * 1989-03-31 1990-10-01 Hiroshi Matsui Imidazole derivatives, methods for their production and pharmaceutical use thereof
DE4023215A1 (de) * 1990-07-21 1992-01-23 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
WO1992005170A1 (en) * 1990-09-13 1992-04-02 Beecham Group Plc Indole ureas as 5 ht receptor antagonist
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5120749A (en) * 1991-02-20 1992-06-09 Abbott Laboratories Platelet activating antagonists
SG44510A1 (en) * 1991-12-18 1997-12-19 Schering Corp Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
EP0597112A4 (en) * 1992-03-27 1994-06-22 Kyoto Pharma Ind Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor.
US5538973A (en) * 1992-03-27 1996-07-23 Kyoto Pharmaceutical Industries, Ltd. Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
JPH0632913U (ja) * 1992-09-18 1994-04-28 三洋電機株式会社 床暖房用パネル
CA2383983C (en) * 1998-03-31 2009-09-29 The Institutes For Pharmaceutical Discovery, Llc Substituted indolealkanoic acids
BR0316583A (pt) * 2002-12-10 2005-10-04 Wyeth Corp Derivados de ácido acético 3-alquil e 3-arilalquil 1h-indol-1-il substituìdo como inibidores do inibidor-1 do ativador do plasminogênio (pai-1)
GB0324763D0 (en) 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
CN101142184A (zh) * 2004-10-12 2008-03-12 解码遗传Ehf公司 用于阻塞性动脉疾病的磺酰胺迫位取代的双环化合物
CA2620171A1 (en) * 2005-08-25 2007-03-01 Schering Corporation Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists
US8399666B2 (en) * 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
CN101490045A (zh) * 2006-05-16 2009-07-22 解码遗传Ehf公司 7-(丙烯酰基)吲哚的制备方法
CA2658496A1 (en) 2006-07-22 2008-01-31 Oxagen Limited 2-{5-fluoro-2-methyl-3-[2-(phenylsulfonyl)benzyl]-1h-indol-yl} acetic acid derivatives and esters thereof having crth2 antagonist activity
TW200920369A (en) * 2007-10-26 2009-05-16 Amira Pharmaceuticals Inc 5-lipoxygenase activating protein (flap) inhibitor
WO2009105140A2 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
US7750027B2 (en) 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
RU2503672C2 (ru) 2008-01-18 2014-01-10 Оксаген Лимитед Соединения, обладающие активностью антагонистов crth2
EP2240444A1 (en) * 2008-01-22 2010-10-20 Oxagen Limited Compounds having crth2 antagonist activity
US20100022613A1 (en) * 2008-01-22 2010-01-28 Oxagen Limited Compounds Having CRTH2 Antagonist Activity
US20110160249A1 (en) * 2008-05-23 2011-06-30 Schaab Kevin Murray 5-lipoxygenase-activating protein inhibitor
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
CN103929961A (zh) * 2011-06-20 2014-07-16 美国阿尔茨海默病研究所公司 化合物及其治疗应用
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407807D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407820D0 (en) 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
WO2019191410A1 (en) * 2018-03-29 2019-10-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Inhibitors for the β-catenin / t-cell factor protein–protein interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (it) * 1963-06-06
US3370063A (en) * 1964-10-05 1968-02-20 Mcneilab Inc Substituted dimethoxy indoles and method of making the same
US3621027A (en) * 1968-03-18 1971-11-16 Endo Lab 1-aminoalkyl-2,6-diaryl 4,5,6,7 tetrahydro-4-oxindales
US3931229A (en) * 1973-08-23 1976-01-06 Warner-Lambert Company 3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles
US4059583A (en) * 1975-11-13 1977-11-22 Mcneil Laboratories, Incorporated Substituted indoles
GR66544B (it) * 1977-08-26 1981-03-26 Wellcome Found
US4140858A (en) * 1977-12-19 1979-02-20 Warner-Lambert Company 3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
DE2960547D1 (en) * 1978-02-24 1981-11-05 Pfizer Ltd 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

Also Published As

Publication number Publication date
LU82224A1 (fr) 1980-06-06
CS253702B2 (en) 1987-12-17
PH15198A (en) 1982-09-17
PL128296B1 (en) 1984-01-31
NO152217B (no) 1985-05-13
NO152217C (no) 1985-08-21
ES8205789A1 (es) 1982-08-01
DE3008632A1 (de) 1980-10-16
ATA125780A (de) 1983-12-15
DE3008632C2 (it) 1988-02-25
NL182959C (nl) 1988-06-16
AR227015A1 (es) 1982-09-15
KE3467A (en) 1984-11-09
IL59524A0 (en) 1980-06-30
BE882113A (fr) 1980-09-08
FI66860B (fi) 1984-08-31
HK89884A (en) 1984-11-23
FI800672A (fi) 1980-09-08
YU61480A (en) 1983-12-31
NL8001351A (nl) 1980-09-09
GR67237B (it) 1981-06-25
IE49542B1 (en) 1985-10-30
DD149525A5 (de) 1981-07-15
FR2450832B1 (it) 1983-04-22
PL222470A1 (it) 1980-12-01
AU516957B2 (en) 1981-07-02
AT375366B (de) 1984-07-25
AU5623180A (en) 1980-09-11
JPS55133380A (en) 1980-10-17
NO800650L (no) 1980-09-08
DK151884C (da) 1988-06-13
ES489220A0 (es) 1981-04-01
ES496889A0 (es) 1982-08-01
ZA801328B (en) 1981-03-25
IE800453L (en) 1980-09-07
HU184727B (en) 1984-10-29
CA1120479A (en) 1982-03-23
NZ193052A (en) 1984-07-06
MY8500285A (en) 1985-12-31
KR850000760B1 (ko) 1985-05-25
KR830001928A (ko) 1983-05-19
SE8001736L (sv) 1980-09-08
JPS6141513B2 (it) 1986-09-16
SE440778B (sv) 1985-08-19
DK42580A (da) 1980-09-08
ES8104278A1 (es) 1981-04-01
IL59524A (en) 1982-11-30
US4273782A (en) 1981-06-16
SG67284G (en) 1985-03-15
IT8020399A0 (it) 1980-03-06
YU41911B (en) 1988-02-29
SU1277894A3 (ru) 1986-12-15
CH649546A5 (de) 1985-05-31
FR2450832A1 (fr) 1980-10-03
PT70914A (en) 1980-04-01
FI66860C (fi) 1984-12-10
DK151884B (da) 1988-01-11

Similar Documents

Publication Publication Date Title
IT1218420B (it) Agenti terapeutici comprendenti 3-1 (immidazolilalchil) indoli (e loro sali di addizione)
IT1127930B (it) Ammidi tetrapeptidiche n-adamantan-sostituite e loro sali
DK32982A (da) Terapeutisk nyttige tetralinderivater
FI802686A (fi) Ftalimidinderivat vilka verkar hindrande pao mentalsjukdomar
NO802946L (no) Imidazo-diazepinderivater
DE2967692D1 (de) Azabicycloalkyl derivatives
DK228780A (da) Plasmidvektor
FI793916A (fi) Spis
FI800709A (fi) Foerstaerkare med reglerad foerstaerkning och en pin-diod foer anvaendning i densamma
ES257501Y (es) Cama articulada perfeccionada
FI794003A (fi) Via huden avsett terapeutiskt behandlingsfoerfarande med isosorbiddinitrat
IT1122748B (it) Sali di coloranti basici,loro preparazione ed impieghi
IT1158712B (it) Derivato di alchilen-ammine e procedimento per la loro preparazione
IT1195309B (it) Composti ai-77 loro sali farmaceuticamente accettabile e procedimento per produrli
FI803736L (fi) Ergolin-derivat foerfarande foer deras framstaellning och terapeutisk komposition
BE875246A (fr) Agents therapeutiques
IT1165040B (it) Alcossialchilidenidrazinopiridazione e procedimento per la loro preparazione
FI803221L (fi) Terapeutiskt anvaendbara pyridinderivat
FI801929A (fi) Terapeutiska pyridylaminotriazolaemnen
IT1206985B (it) Amminoalchilguanidine sostituite eprocedimento per la loro preparazione
IT8147787A0 (it) Composti piperazinici procedimento per prepararli e loro impiego
IT1130215B (it) 3-ariltio-4-idrossipirrolidine 1-sostituite e procedimento per la loro preparazione
IT1143906B (it) Tiocarnitine procedimento per la loro preparazione e loro uso terapeutico
IT7948940A0 (it) Indoli sostituiti e loro procedimento di preparazione
IT8147788A0 (it) Composti piperazinici procedimento per prepararli e loro impiego